Gene Therapy for GM1 Gangliosidosis
GM1 gangliosidosis (GM1) is a rare genetic disorder that progressively damages cells primarily in the brain and spinal cord, and other tissues as well. Learn how gene therapy may target the cause of disease to slow or stop its progression, along with helpful information on clinical trials and staying informed. The subtitling of these videos was funded in part by a donation from Pfizer, Inc.
▶︎
GM1 Gangliosidosis Disease Overview - Dr. Cynthia Tifft
▶︎
A Story of Hope and Fight for Life, Nella's Fight, Juvenile GM1 Gangliosidosis, GM1 EL-PFDD
▶︎
Ganglioside formation
▶︎
Living with LGMD - Three perspectives
▶︎
Gene Therapy Vectors
▶︎
Trump Gets Booed and Falls Asleep at NBA Finals, Spreads Deranged CA Election Lies: A Closer Look
▶︎
Why Ancient Humans Developed Different Blood Types?
▶︎
Gene Therapy in Hemophilia: Common Concerns in Gene Therapy
▶︎
Epigenetics: Can we change our genes? - BBC World Service
▶︎
Congressional Briefing: Gene Therapy Approaches for Inherited Hearing Loss
▶︎
The Unfair Advantages Of Your Eye Color
▶︎
Death Is Not The End — Feynman Explains What Physics Says About Dying
▶︎
Brain-swooshing exercise could ward off dementia | Prof. Patrick Drew & Francesco Costanzo
▶︎
Immune Responses to AAV-Based Gene Therapy
▶︎
Why is it so hard to cure cancer? - Kyuson Yun
▶︎
Tay-Sachs disease - causes, symptoms, diagnosis, treatment, pathology
▶︎
Seniors No 1 Oncologist Reveals Foods to Starve Cancer Cells Naturally After 50! |Dr. William Li
▶︎
Gene Therapy for Wilson Disease
▶︎
Gene Therapy for Treatment of Hemophilia: An Introduction to AAV Vector Gene Transfer
▶︎